HomeCompareFITB vs HRC

FITB vs HRC: Dividend Comparison 2026

FITB yields 3.45% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRC wins by $2.07M in total portfolio value
10 years
FITB
FITB
● Live price
3.45%
Share price
$44.68
Annual div
$1.54
5Y div CAGR
45.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$190.1K
Annual income
$82,140.41
Full FITB calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — FITB vs HRC

📍 HRC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFITBHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FITB + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FITB pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FITB
Annual income on $10K today (after 15% tax)
$292.97/yr
After 10yr DRIP, annual income (after tax)
$69,819.35/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, HRC beats the other by $1,140,095.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FITB + HRC for your $10,000?

FITB: 50%HRC: 50%
100% HRC50/50100% FITB
Portfolio after 10yr
$1.22M
Annual income
$752,785.02/yr
Blended yield
61.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FITB right now

FITB
Analyst Ratings
1
Strong
26
Buy
22
Hold
2
Sell
Consensus: Buy
Price Target
$56.90
+27.4% upside vs current
Range: $50.00 — $61.00
Altman Z
0.2
Piotroski
8/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FITB buys
0
HRC buys
0
No recent congressional trades found for FITB or HRC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFITBHRC
Forward yield3.45%11.38%
Annual dividend / share$1.54$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR45.8%40.3%
Portfolio after 10y$190.1K$2.26M
Annual income after 10y$82,140.41$1,423,429.65
Total dividends collected$157.8K$2.14M
Payment frequencyquarterlyquarterly
SectorFinancialsStock
Analyst consensusBuyHold

Year-by-year: FITB vs HRC ($10,000, DRIP)

YearFITB PortfolioFITB Income/yrHRC PortfolioHRC Income/yrGap
1← crossover$11,203$502.53$12,296$1,595.93$1.1KHRC
2$12,754$767.11$15,730$2,573.05$3.0KHRC
3$14,837$1,190.02$21,147$4,316.00$6.3KHRC
4$17,762$1,886.34$30,235$7,608.15$12.5KHRC
5$22,082$3,077.09$46,615$14,263.36$24.5KHRC
6$28,840$5,212.79$78,712$28,834.27$49.9KHRC
7$40,136$9,277.03$148,063$63,841.01$107.9KHRC
8$60,538$17,592.13$315,890$157,462.80$255.4KHRC
9$100,932$36,156.20$778,498$440,495.17$677.6KHRC
10$190,137$82,140.41$2,256,422$1,423,429.65$2.07MHRC

FITB vs HRC: Complete Analysis 2026

FITBFinancials

Fifth Third Bancorp operates as a diversified financial services company in the United States. The company's Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and cash management, foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. Its Branch Banking segment provides a range of deposit and loan products to individuals and small businesses. This segment offers checking and savings accounts, home equity loans and lines of credit, credit cards, and loans for automobiles and personal financing needs, as well as cash management services for small businesses. The company's Consumer Lending segment engages in direct lending activities that include origination, retention, and servicing of residential mortgage and home equity loans or lines of credit; and indirect lending activities, including loans to consumers through correspondent lenders and automobile dealers. Fifth Third Bancorp's Wealth & Asset Management segment provides various investment alternatives for individuals, companies, and not-for-profit organizations. It offers retail brokerage services to individual clients; and broker dealer services to the institutional marketplace. This segment also provides wealth planning, investment management, banking, insurance, and trust and estate services; and advisory services for institutional clients comprising middle market businesses, non-profits, states, and municipalities. As of December 31, 2021, the company operated 1,117 full-service banking centers and 2,322 ATMs in Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, North Carolina, and South Carolina. Fifth Third Bancorp was founded in 1858 and is headquartered in Cincinnati, Ohio.

Full FITB Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this FITB vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FITB vs SCHDFITB vs JEPIFITB vs OFITB vs KOFITB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.